- recruitingPHASE4
Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma
This study looks at how well a treatment combining two drugs, nivolumab and cabozantinib, works for older patients (70 and over) with advanced kidney cancer. It aims to see how patients respond to this treatment in real-life use.
France - recruitingPHASE1, PHASE2
Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer
This study is testing a new vaccine called Modi-1 Moditope for advanced cancers like breast, head and neck, ovarian, or kidney cancer. It aims to see if it's safe, and if it can help the body fight cancer, alone or with other treatments.
United Kingdom - recruitingPHASE2
WIRE - Novel Treatments in Renal Cell Cancer
This study looks at new medicines for kidney cancer that can be removed by surgery. Patients take a medicine for a short time before their operation. We want to see how these medicines affect the cancer and the body, to find better ways to treat this type of kidney cancer.
United Kingdom